BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26708618)

  • 1. FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells.
    Junhom C; Weerapreeyakul N; Tanthanuch W; Thumanu K
    Exp Cell Res; 2016 Jan; 340(1):71-80. PubMed ID: 26708618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial least squares regression and fourier transform infrared (FTIR) microspectroscopy for prediction of resistance in hepatocellular carcinoma HepG2 cells.
    Junhom C; Weerapreeyakul N; Tanthanuch W; Thumanu K
    Exp Cell Res; 2017 Feb; 351(1):82-90. PubMed ID: 28057471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy.
    Zwielly A; Gopas J; Brkic G; Mordechai S
    Analyst; 2009 Feb; 134(2):294-300. PubMed ID: 19173052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput microcultivation protocol for FTIR spectroscopic characterization and identification of fungi.
    Shapaval V; Møretrø T; Suso HP; Asli AW; Schmitt J; Lillehaug D; Martens H; Böcker U; Kohler A
    J Biophotonics; 2010 Aug; 3(8-9):512-21. PubMed ID: 20414905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
    Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
    Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP.
    Bao W; Zhu F; Duan Y; Yang Y; Cai H
    Biomed Pharmacother; 2015 Mar; 70():97-102. PubMed ID: 25776486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
    Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
    Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells.
    Fang D; Guo Y; Zhu Z; Chen W
    Bosn J Basic Med Sci; 2012 Feb; 12(1):4-9. PubMed ID: 22364296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance reduces sensitivity to Cis-platinum and promotes adhesion, migration and invasion in HepG2 cells.
    Li LJ; Li GD; Wei HL; Chen J; Liu YM; Li F; Xie B; Wang B; Li CL
    Asian Pac J Cancer Prev; 2014; 15(7):3123-8. PubMed ID: 24815457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.
    Thumanu K; Sangrajrang S; Khuhaprema T; Kalalak A; Tanthanuch W; Pongpiachan S; Heraud P
    J Biophotonics; 2014 Apr; 7(3-4):222-31. PubMed ID: 24639420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells.
    Chowdhury KD; Sarkar A; Chatterjee S; Patra D; Sengupta D; Banerjee S; Chakraborty P; Sadhukhan GC
    Environ Toxicol Pharmacol; 2019 May; 68():120-132. PubMed ID: 30889542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study.
    Chaudhary H; Jena PK; Seshadri S
    Nutr Cancer; 2013; 65(5):775-80. PubMed ID: 23859045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.
    Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M
    Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
    Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):95-8. PubMed ID: 14980111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
    Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
    Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma.
    Li X; Zeng X; Sun J; Li H; Wu P; Fung KP; Liu F
    Cancer Lett; 2014 Jun; 348(1-2):146-55. PubMed ID: 24680709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTIR spectroscopy reveals lipid droplets in drug resistant laryngeal carcinoma cells through detection of increased ester vibrational bands intensity.
    Rak S; De Zan T; Stefulj J; Kosović M; Gamulin O; Osmak M
    Analyst; 2014 Jul; 139(13):3407-15. PubMed ID: 24834449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.
    Zhang L; Li Y; Qiao L; Zhao Y; Wei Y; Li Y
    Int J Oncol; 2015 Aug; 47(2):632-40. PubMed ID: 26035065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.